Cell MedX (OTCMKTS:CMXC) Share Price Passes Below Fifty Day Moving Average of $0.03

Cell MedX Corp. (OTCMKTS:CMXCGet Free Report)’s share price passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.03 and traded as low as $0.02. Cell MedX shares last traded at $0.05, with a volume of 4,700 shares.

Cell MedX Price Performance

The business’s fifty day simple moving average is $0.03 and its 200 day simple moving average is $0.03.

Cell MedX Company Profile

(Get Free Report)

Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.

Recommended Stories

Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.